SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles

This article has been Reviewed by the following groups

Read the full article

Abstract

SARS-CoV-2 is a novel coronavirus currently causing a pandemic. We show that the majority of amino acid positions, which differ between SARS-CoV-2 and the closely related SARS-CoV, are differentially conserved suggesting differences in biological behaviour. In agreement, novel cell culture models revealed differences between the tropism of SARS-CoV-2 and SARS-CoV. Moreover, cellular ACE2 (SARS-CoV-2 receptor) and TMPRSS2 (enables virus entry via S protein cleavage) levels did not reliably indicate cell susceptibility to SARS-CoV-2. SARS-CoV-2 and SARS-CoV further differed in their drug sensitivity profiles. Thus, only drug testing using SARS-CoV-2 reliably identifies therapy candidates. Therapeutic concentrations of the approved protease inhibitor aprotinin displayed anti-SARS-CoV-2 activity. The efficacy of aprotinin and of remdesivir (currently under clinical investigation against SARS-CoV-2) were further enhanced by therapeutic concentrations of the proton pump inhibitor omeprazole (aprotinin 2.7-fold, remdesivir 10-fold). Hence, our study has also identified anti-SARS-CoV-2 therapy candidates that can be readily tested in patients.

Article activity feed

  1. SciScore for 10.1101/2020.04.03.024257: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Institutional Review Board Statementnot detected.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.
    Sex as a biological variablenot detected.
    Cell Line AuthenticationAuthentication: Cells were regularly authenticated by short tandem repeat (STR) analysis and tested for mycoplasma contamination.
    Contamination: Cells were regularly authenticated by short tandem repeat (STR) analysis and tested for mycoplasma contamination.

    Table 2: Resources

    Antibodies
    SentencesResources
    Detection occurred by using specific antibodies against β-actin (1:2500 dilution, Sigma-Aldrich, Munich, Germany), ACE2, and TMPRSS2 (both 1:1000 dilution, abcam, Cambridge, UK)
    β-actin
    suggested: None
    TMPRSS2
    suggested: None
    Receptor blocking experiments: To investigate whether ACE2 or DPP4 receptors are involved in SARS-CoV-2 internalisation and replication, Caco2 cells were pre-treated for 30 min at 37°C with goat antibody directed against the human ACE2 or DDP4 ectodomain (R&D Systems, Wiesbaden-Nordenstadt, Germany).
    DPP4
    suggested: None
    ACE2
    suggested: None
    Immunostaining for double-stranded RNA: Immunostaining was performed as previously described [Cinatl et al., 1995], using a monoclonal antibody directed against double-stranded RNA (1:150 dilution, SCICONS J2, mouse, IgG2a, kappa chain, English & Scientific Consulting Kft.,
    mouse, IgG2a
    suggested: None
    Experimental Models: Cell Lines
    SentencesResources
    293 cells (PD-02-01; Microbix Bisosystems Inc.) and 293/ACE2 cells [Kamitani et al., 2006] (kindly provided by Shinji Makino, UTMB, Galveston, Texas) were cultured in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% FBS), 50 IU/ mL penicillin, and 50µg/ mL streptomycin.
    293
    suggested: None
    293/ACE2
    suggested: RRID:CVCL_DR94)
    Receptor blocking experiments: To investigate whether ACE2 or DPP4 receptors are involved in SARS-CoV-2 internalisation and replication, Caco2 cells were pre-treated for 30 min at 37°C with goat antibody directed against the human ACE2 or DDP4 ectodomain (R&D Systems, Wiesbaden-Nordenstadt, Germany).
    Caco2
    suggested: None
    Software and Algorithms
    SentencesResources
    Fifty-three SARS-CoV genome sequences were downloaded from VIPR [Pickett et al., 2012; Pickett et al., 2012A] restricted to sequences with a collection year between 2003-2004 and a human or unknown host.
    VIPR
    suggested: (vipR, RRID:SCR_010685)
    Frames (ORFs) were extracted using EMBOSS getorf
    EMBOSS
    suggested: (EMBOSS, RRID:SCR_008493)
    These ORFs were matched to known proteins using BLAST, and fragments and mismatches were discarded.
    BLAST
    suggested: (BLASTX, RRID:SCR_001653)
    Where structures were not available they were modelled using Phyre2 [Kelley et al., 2015]
    Phyre2
    suggested: None
    SDPs were mapped onto protein structures using PyMOL from structures obtained from the Protein Databank (PDB).
    PyMOL
    suggested: (PyMOL, RRID:SCR_000305)

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).


    Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We found bar graphs of continuous data. We recommend replacing bar graphs with more informative graphics, as many different datasets can lead to the same bar graph. The actual data may suggest different conclusions from the summary statistics. For more information, please see Weissgerber et al (2015).


    Results from JetFighter: We did not find any issues relating to colormaps.


    Results from rtransparent:
    • No conflict of interest statement was detected. If there are no conflicts, we encourage authors to explicit state so.
    • No funding statement was detected.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.